Skip to content
A3
Tissue
Peripheral blood
Disease
Childhood T acute lymphoblastic leukemia
Metastatic site
Not reported (peripheral blood T-ALL)

Documents

A3

Cell line · Product number 305143

A3 cells are human T lymphoblasts derived from the Jurkat cell line obtained from the laboratory of Gerald Crabtree at Stanford University. These cells po...

US$395.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

A3 cells are human T lymphoblasts derived from the Jurkat cell line obtained from the laboratory of Gerald Crabtree at Stanford University. These cells possess a lymphoblast morphology, grow in suspension and are highly relevant in studying acute T cell leukaemia, 3D cell culture applications, immune system disorder research, and immunology.

These cells are derived from the Jurkat cell line, which was treated with Fas Antibody to obtain a low spontaneous resistance rate to Fas-mediated apoptosis. This characteristic makes A3 cells highly valuable for investigating immune system dysregulation and identifying potential therapeutic targets.

Tissue
Peripheral blood
Disease
Childhood T acute lymphoblastic leukemia
Metastatic site
Not reported (peripheral blood T-ALL)
Applications
T-ALL research; T cell leukemia biology; drug sensitivity studies; immunophenotyping; pediatric leukemia models

02Classification

Organism
Human
Growth properties
Suspension
GMO status
Non-GMO
GMO status details
No genetic modification; wildtype T-ALL cell line
Biosafety level
1

03Characteristics

Morphology
Lymphoblast
Cell type
T lymphoblasts

04Identifiers

Citation
A3 (Cytion catalog number 305143)
NCBI TaxID
9606
Cellosaurus
CVCL_1061

05Handling and culture

Culture medium
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Subculturing
Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation.
Split ratio
1 to 4
Fluid renewal
2 to 3 times per week
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

06Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.